Suzhou Basecare Medical Corporation Limited (HKG:2170)

Hong Kong · Delayed Price · Currency is HKD

1.400

-0.010 (-0.71%)

Jul 31, 2026, 3:55 PM HKT

HKG:2170 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	233.27	233.27	299.11	207.98	140.9	107.3
Revenue Growth	-15.39%	-22.01%	43.82%	47.60%	31.32%	32.29%
Gross Profit	123.61	123.61	136.22	91.35	59.53	51.15
Operating Income	-210.79	-210.79	-267.79	-241.67	-216.04	-132.38
Net Income	-223.46	-223.46	-237.03	-191.69	-122.66	-143.65
Earnings Per Share	-0.82	-0.82	-0.87	-0.70	-0.45	-0.54
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Australia	179.63	179.63	148.23	62.14
The Prc	128.77	128.77	201.95	163.19
Inter-segment	-75.13	-75.13	-51.07	-17.36
Total	233.27	233.27	299.11	207.98

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	445.52	445.52	687.16	945.71	1,333	1,524
Total Debt	343.36	343.36	328.42	281.92	75.54	48.57
Net Cash (Debt)	102.16	102.16	358.74	663.8	1,258	1,476
Net Cash Growth	-49.74%	-71.52%	-45.96%	-47.23%	-14.75%	811.97%
Net Cash Per Share	0.37	0.37	1.31	2.43	4.60	5.56

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-167.88	-167.88	-229.12	-267.23	-188.77	-197.85
Capital Expenditures	-85.57	-85.57	-93.3	-104.21	-128.45	-28.9
Free Cash Flow	-253.45	-253.45	-322.41	-371.44	-317.22	-226.75
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	52.99%	52.99%	45.54%	43.92%	42.25%	47.67%
Operating Margin	-90.36%	-90.36%	-89.53%	-116.20%	-153.33%	-123.38%
Pretax Margin	-97.39%	-97.39%	-80.35%	-94.40%	-89.86%	-117.19%
Profit Margin	-95.79%	-95.79%	-79.25%	-92.17%	-87.06%	-133.88%
FCF Margin	-108.65%	-108.65%	-107.79%	-178.60%	-225.14%	-211.33%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	1.48	1.96	2.36	2.81	6.41	13.91